{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:40:29Z","timestamp":1767865229960,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.virs.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:14:23Z","timestamp":1669176863000},"page":"786-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages"],"prefix":"10.1016","volume":"37","author":[{"given":"Tiandan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-7807","authenticated-orcid":false,"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.11.007_bib1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.chom.2022.05.001","article-title":"Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages","volume":"30","author":"Ai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2022.11.007_bib2","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41591-022-01832-0","article-title":"Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years","volume":"28","author":"Arbel","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.11.007_bib4","article-title":"BA.2.12.1 is a new omicron offshoot that is a highly contagious but not severe disease","volume":"79","author":"Beheshti","year":"2022","journal-title":"Ann Med Surg (Lond)."},{"key":"10.1016\/j.virs.2022.11.007_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated Omicron variant puts scientists on alert","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib7","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.chom.2022.09.018","article-title":"Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75","volume":"30","author":"Cao","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2022.11.007_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron","volume":"602","author":"Carre\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41591-022-01704-7","article-title":"Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination","volume":"28","author":"Cheng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41423-022-00838-5","article-title":"T\u00a0cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant","volume":"19","author":"Choi","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virs.2022.11.007_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.11.007_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","article-title":"Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron","volume":"185","author":"Cui","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib16","series-title":"Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa","author":"Davies","year":"2022"},{"key":"10.1016\/j.virs.2022.11.007_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib18","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/jmv.27601","article-title":"Emergence of Omicron third lineage BA.3 and its importance","volume":"94","author":"Desingu","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.virs.2022.11.007_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-021-00525-3","article-title":"The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity","volume":"6","author":"Gao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2022.11.007_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron\u2013reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Science Immunology"},{"key":"10.1016\/j.virs.2022.11.007_bib22","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","article-title":"Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine","volume":"185","author":"Goel","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/v14020294","article-title":"The spread of SARS-CoV-2 variant omicron with a doubling time of 2.0\u20133.3 Days can Be explained by immune evasion","volume":"14","author":"Grabowski","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.11.007_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2022.11.007_bib26","first-page":"649","article-title":"SingaporeAssociation between COVID-19 Vaccination Coverage and Case Fatality Ratio:a Comparative Study - Hong Kong SAR, China and Singapore, December 2021-March 2022","volume":"4","author":"He","year":"2022","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.virs.2022.11.007_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T\u00a0cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib30","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1038\/s41467-022-32396-9","article-title":"Omicron BA.4\/BA.5 escape neutralizing immunity elicited by BA.1 infection","volume":"13","author":"Khan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.11.007_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.09.018","article-title":"Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA. subvariants, including BA.4 and BA.5","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8590","article-title":"SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine","volume":"7","author":"Kotaki","year":"2022","journal-title":"Science Immunology"},{"key":"10.1016\/j.virs.2022.11.007_bib34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.virs.2022.11.007_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the delta (B.1.617.2) and omicron (B.1.1.529) variants \u2014 United States, june 2021\u2013january 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.virs.2022.11.007_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-022-01887-z","article-title":"Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1\/BA.1.1 or BA.2 subvariant infection in southern California","volume":"28","author":"Lewnard","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib37","article-title":"The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta","volume":"29","author":"Liu","year":"2022","journal-title":"J.\u00a0Trav. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib40","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1093\/cid\/ciab1041","article-title":"Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients","volume":"75","author":"Lu","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2022.11.007_bib41","series-title":"SARS-CoV-2 Omicron Neutralization by Therapeutic Antibodies, Convalescent Sera, and Post-mRNA Vaccine Booster","author":"Lusvarghi","year":"2021"},{"key":"10.1016\/j.virs.2022.11.007_bib42","article-title":"Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant","volume":"3","author":"Lyke","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.virs.2022.11.007_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/22221751.2022.2031311","article-title":"Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents","volume":"11","author":"Ma","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2022.11.007_bib44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein\u2013ACE2 complex","volume":"375","author":"Mannar","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.007_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.801431","article-title":"SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron","volume":"13","author":"Mazzoni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.11.007_bib46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.abn8652","article-title":"Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement","volume":"375","author":"McCallum","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.007_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib48","first-page":"8012","article-title":"Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.virs.2022.11.007_bib49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","article-title":"Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost","volume":"607","author":"Muecksch","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib50","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.abn7591","article-title":"Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine\u2013elicited human sera","volume":"375","author":"Muik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.007_bib51","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T\u00a0cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 omicron infection","volume":"386","author":"Nemet","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm11010030","article-title":"Relative reproduction number of SARS-CoV-2 omicron (B.1.1.529) compared with delta variant in South Africa","volume":"11","author":"Nishiura","year":"2022","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib54","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.lanepe.2022.100466","article-title":"Effectiveness of a Fourth Dose of mRNA COVID-19 Vaccine against All-Cause Mortality in Long-Term Care Facility Residents and in the Oldest Old: A Nationwide, Retrospective Cohort Study in Sweden","volume":"21","author":"Nordstrom","year":"2022","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.virs.2022.11.007_bib55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.11.007_bib56","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.abm1208","article-title":"Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness","volume":"376","author":"Obermeyer","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.007_bib57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.09.015","article-title":"Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant","volume":"30","author":"Qu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2022.11.007_bib59","series-title":"Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination against SARS-CoV-2 BA.2.12.1 and BA.4\/5 Variants","author":"Qu","year":"2022"},{"key":"10.1016\/j.virs.2022.11.007_bib60","article-title":"Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4\/5 and BA.2.12.1 Subvariants","author":"Qu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.virs.2022.11.007_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106261","article-title":"The Omicron subvariant BA.2: birth of a new challenge during the COVID-19 pandemic","volume":"99","author":"Rahimi","year":"2022","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.virs.2022.11.007_bib62","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of covid-19 mRNA vaccine against omicron","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance","volume":"10","author":"Ren","year":"2022","journal-title":"World J. Clin. Cases."},{"key":"10.1016\/j.virs.2022.11.007_bib64","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMc2119236","article-title":"SARS-CoV-2 omicron variant neutralization in serum from vaccinated and convalescent persons","volume":"386","author":"R\u00f6ssler","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib65","first-page":"2022","article-title":"Virological characteristics of the SARS-CoV-2 omicron BA.2.75","author":"Saito","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.virs.2022.11.007_bib66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 omicron variant","volume":"386","author":"Schmidt","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib67","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/eji.202249841","article-title":"Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies","volume":"52","author":"Schulz","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virs.2022.11.007_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106861","article-title":"Could the new BA.2.75 sub-variant lead to another COVID-19 wave in the world? - Correspondence","volume":"105","author":"Shaheen","year":"2022","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.virs.2022.11.007_bib69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(22)00129-3","article-title":"Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study","volume":"22","author":"Sheward","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2022.11.007_bib70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib71","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.immuni.2022.04.002","article-title":"Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant","volume":"55","author":"Sokal","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2022.11.007_bib72","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/microorganisms10102090","article-title":"SARS-CoV-2 Omicron BA.2.75 Variant May Be Much More Infective than Preexisting Variants Based on In Silico Model","volume":"10","author":"Sugano","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.virs.2022.11.007_bib73","doi-asserted-by":"crossref","first-page":"933","DOI":"10.46234\/ccdcw2020.255","article-title":"China CDC Weekly: A Trusted Resource on Public Health","volume":"2","author":"Tan","year":"2020","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.virs.2022.11.007_bib74","first-page":"S2666","article-title":"Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5","volume":"22","author":"Tan","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virs.2022.11.007_bib75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.virs.2022.11.007_bib76","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib77","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib78","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-022-01753-y","article-title":"Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants","volume":"28","author":"Tseng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib79","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","article-title":"Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum","volume":"185","author":"Tuekprakhon","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.007_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","article-title":"Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2","volume":"607","author":"Uraki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib82","article-title":"Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding Domain","author":"Wang","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.virs.2022.11.007_bib83","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapediatrics.2022.0945","article-title":"Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 Years in the US","volume":"176","author":"Wang","year":"2022","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.virs.2022.11.007_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib85","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.chom.2022.09.002","article-title":"Antigenic characterization e4. of the SARS-CoV-2 Omicron subvariant BA.2.75","volume":"30","author":"Wang","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2022.11.007_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"Westendorf","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2022.11.007_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(22)00981-3","article-title":"Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa","volume":"400","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.11.007_bib88","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","article-title":"Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern","volume":"28","author":"Wratil","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib89","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.abn8863","article-title":"Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody","volume":"375","author":"Yin","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.007_bib90","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMc2201849","article-title":"Neutralization of the SARS-CoV-2 omicron BA.1 and BA.2 variants","volume":"386","author":"Yu","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejim.2022.08.009","article-title":"Knowing the new Omicron BA.2.75 variant (\u2019Centaurus\u2019): a simulation study","volume":"105","author":"Zappa","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.virs.2022.11.007_bib92","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2022.11.007_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/22221751.2021.2017757","article-title":"The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2022.11.007_bib94","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.007_bib95","doi-asserted-by":"crossref","first-page":"n8897","DOI":"10.1126\/science.abn8897","article-title":"Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529","volume":"376","author":"Zhou","year":"2022","journal-title":"Science"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:19:34Z","timestamp":1761851974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1995820X22001912"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.11.007","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}